Johnson & Johnson vs Merit Medical Systems, Inc. — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
7.6
Bullish
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
MMSI
Consensus analyst target of $90.64 is 46% above current price.
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $90.64 (+46.2%)
11 analysts
Fundamentals
JNJ
MMSI
26.3×
Trailing P/E
26.7×
17.9×
Forward P/E
14.1×
21.8%
Profit Margin
9.0%
68.0%
Gross Margin
48.7%
26.4%
ROE
9.1%
9.9%
Revenue Growth
7.5%
-52.9%
Earnings Growth
38.8%
0.33
Beta
0.65
—
Price / Book
—
$546.9B
Market Cap
$3.7B
$146 – $252
52-Week Range
$61 – $100
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →